Biosota Supports Mater Foundation as High-MGO Manuka Honey Revealed in Emerging Breast Cancer Research

Gold Coast, Australia, 31 March 2026 - In recognition of International Women’s Day, Australian Manuka honey producer Biosota Organics is reinforcing its commitment to women’s health through fundraising for the Mater Foundation.

Through this initiative, Biosota Organics raised $1,540 in March, contributing to vital research, care and support services for women and families across Australia.

During the campaign, customers contributed through their purchases, with AU$10 from each qualifying order donated to the Mater Foundation. The Biosota team also participated in the “5K Your Way” community fundraising walk supporting Mater Chicks in Pink, which provides personalised support for women experiencing breast cancer (1, 2).

This initiative forms part of the Mater International Women’s Day Fun Run, one of Queensland’s largest community events promoting breast cancer awareness. In March 2026, more than 23,000 participants helped raise over $2 million, transforming Brisbane into the iconic “Sea of Pink” in support of women affected by breast cancer.

“Supporting initiatives that advance women’s health is deeply aligned with our values,” said Biosota founder Andrey Zubko.

“Our customers are increasingly focused on proactive wellbeing, particularly around immunity, inflammation and cancer recovery, and Manuka honey has long been valued for its natural bioactive properties. It’s encouraging to see scientific research exploring how these compounds, especially in high-MGO varieties, may have broader potential.”

High-MGO Manuka Honey Gains Attention in Emerging Breast Cancer Research

Interest in Manuka honey’s bioactive compounds, particularly methylglyoxal (MGO), has accelerated, with higher MGO levels indicating greater concentrations of these compounds.

Recent preclinical research (2024–2025), including studies referenced by UCLA Health, has explored Manuka honey in breast cancer models. Findings suggest it may inhibit tumour growth and trigger apoptosis (programmed cancer cell death), with one study reporting up to an 84% reduction in tumour growth in mice with estrogen receptor-positive (ER+) breast cancer. Laboratory studies have also shown potential modulation of key signalling pathways (AMPK/AKT/mTOR) and anti-inflammatory effects.

These early findings indicate that high-activity Manuka honey may interfere with cancer cell proliferation and are contributing to growing global interest in its role as a complementary or less-toxic therapeutic approach.

However, researchers emphasise that current evidence is limited to preclinical models, and further human studies are required.

“High-MGO Manuka honey is gaining recognition as a natural functional food with unique bioactive properties,” Zubko added. “While the research is promising, it’s important to be clear that Manuka honey is not a treatment or substitute for medical care.”

References:

1. Mater Foundation. 5K Your Way – Mater International Women’s Day Fun Run 2026.
   Link: https://fundraise.mater.org.au/event/funrun-2026/5kyw
2. Mater Foundation. Mater Chicks in Pink – Supporting women with breast cancer.
   Link: https://www.materfoundation.org.au/what-we-do/mater-chicks-in-pink